Literature DB >> 28735752

Conformational Changes of CFTR upon Phosphorylation and ATP Binding.

Zhe Zhang1, Fangyu Liu2, Jue Chen3.   

Abstract

The cystic fibrosis transmembrane conductance regulator (CFTR) is an anion channel evolved from an ATP-binding cassette transporter. CFTR channel gating is strictly coupled to phosphorylation and ATP hydrolysis. Previously, we reported essentially identical structures of zebrafish and human CFTR in the dephosphorylated, ATP-free form. Here, we present the structure of zebrafish CFTR in the phosphorylated, ATP-bound conformation, determined by cryoelectron microscopy to 3.4 Å resolution. Comparison of the two conformations shows major structural rearrangements leading to channel opening. The phosphorylated regulatory domain is disengaged from its inhibitory position; the nucleotide-binding domains (NBDs) form a "head-to-tail" dimer upon binding ATP; and the cytoplasmic pathway, found closed off in other ATP-binding cassette transporters, is cracked open, consistent with CFTR's unique channel function. Unexpectedly, the extracellular mouth of the ion pore remains closed, indicating that local movements of the transmembrane helices can control ion access to the pore even in the NBD-dimerized conformation.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ABC transporter; ATP-bound; CFTR; anion channel; cryo-EM; phosphorylated form

Mesh:

Substances:

Year:  2017        PMID: 28735752     DOI: 10.1016/j.cell.2017.06.041

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  83 in total

1.  Structural mechanisms for defective CFTR gating caused by the Q1412X mutation, a severe Class VI pathogenic mutation in cystic fibrosis.

Authors:  Jiunn-Tyng Yeh; Ying-Chun Yu; Tzyh-Chang Hwang
Journal:  J Physiol       Date:  2018-12-02       Impact factor: 5.182

Review 2.  Microbiology catches the cryo-EM bug.

Authors:  Lesley A Earl; Veronica Falconieri; Sriram Subramaniam
Journal:  Curr Opin Microbiol       Date:  2018-04-12       Impact factor: 7.934

Review 3.  Pharmacological analysis of CFTR variants of cystic fibrosis using stem cell-derived organoids.

Authors:  Kevin G Chen; Pingyu Zhong; Wei Zheng; Jeffrey M Beekman
Journal:  Drug Discov Today       Date:  2019-06-04       Impact factor: 7.851

Review 4.  Structural Variability in the RLR-MAVS Pathway and Sensitive Detection of Viral RNAs.

Authors:  Qiu-Xing Jiang
Journal:  Med Chem       Date:  2019       Impact factor: 2.745

5.  Proteomic interaction profiling reveals KIFC1 as a factor involved in early targeting of F508del-CFTR to degradation.

Authors:  Sara Canato; João D Santos; Ana S Carvalho; Kerman Aloria; Margarida D Amaral; Rune Matthiesen; André O Falcao; Carlos M Farinha
Journal:  Cell Mol Life Sci       Date:  2018-07-31       Impact factor: 9.261

6.  Protein kinase A phosphorylation potentiates cystic fibrosis transmembrane conductance regulator gating by relieving autoinhibition on the stimulatory C terminus of the regulatory domain.

Authors:  Jeng-Haur Chen
Journal:  J Biol Chem       Date:  2020-02-26       Impact factor: 5.157

Review 7.  NM23 proteins: innocent bystanders or local energy boosters for CFTR?

Authors:  Richmond Muimo; Hani Mm Alothaid; Anil Mehta
Journal:  Lab Invest       Date:  2017-12-18       Impact factor: 5.662

Review 8.  Never at rest: insights into the conformational dynamics of ion channels from cryo-electron microscopy.

Authors:  Carus Lau; Mark J Hunter; Alastair Stewart; Eduardo Perozo; Jamie I Vandenberg
Journal:  J Physiol       Date:  2018-03-05       Impact factor: 5.182

Review 9.  Ion Channel Modulators in Cystic Fibrosis.

Authors:  Martina Gentzsch; Marcus A Mall
Journal:  Chest       Date:  2018-05-08       Impact factor: 9.410

10.  Folding and Misfolding of Human Membrane Proteins in Health and Disease: From Single Molecules to Cellular Proteostasis.

Authors:  Justin T Marinko; Hui Huang; Wesley D Penn; John A Capra; Jonathan P Schlebach; Charles R Sanders
Journal:  Chem Rev       Date:  2019-01-04       Impact factor: 60.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.